SEER 1000

K130785 · Getemed Medizin- Und Informationstechnik AG · MWJ · Jul 26, 2013 · Cardiovascular

Device Facts

Record IDK130785
Device NameSEER 1000
ApplicantGetemed Medizin- Und Informationstechnik AG
Product CodeMWJ · Cardiovascular
Decision DateJul 26, 2013
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 870.2800
Device ClassClass 2

Intended Use

The SEER 1000 digital Holter recorder is intended to continuously record ECG data. The SEER 1000 performs no cardiac analysis by itself and is intended to be used with an ECG analysis software package. The recorded data are downloaded to a PC for analysis and subsequent evaluation by a trained physician or health care professional.

Device Story

SEER 1000 is a compact, ambulatory Holter ECG recorder. It acquires 2 or 3 channels of ECG signals from the chest surface for up to 7 days. Data is stored on-board in flash memory. Device uses Bluetooth to interface with PC or mobile applications (iPhone, iPod, iPad) for patient demographic entry, recording control, and signal quality checks during hookup. After recording, data is downloaded to a PC via USB for analysis by a physician or healthcare professional. Device lacks a display and performs no on-board cardiac analysis. It is intended for clinical use to assist in diagnosing cardiac conditions by providing continuous ECG data for subsequent evaluation.

Clinical Evidence

No clinical testing was performed. Safety and effectiveness were established through bench testing, including electromagnetic compatibility (IEC 60601-1-2), electrical safety (IEC 60601-1), and ECG performance (AAMI ANSI EC 38).

Technological Characteristics

Ambulatory Holter ECG recorder; 2 or 3 channels; flash memory storage; Bluetooth connectivity for mobile/PC interface; USB for data download. Complies with IEC 60601-1 (electrical safety), IEC 60601-1-2 (EMC), and AAMI ANSI EC 38 (ECG performance).

Indications for Use

Indicated for patients requiring long-term continuous ECG recording, including those with palpitations, syncope, chest pain, shortness of breath, or those needing monitoring of cardiac functionality.

Regulatory Classification

Identification

A medical magnetic tape recorder is a device used to record and play back signals from, for example, physiological amplifiers, signal conditioners, or computers.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ # JUL 2 6 2013 | DHF - Technical Documentation | Image: getemed logo | |-------------------------------|---------------------| | SEER 1000 | 1015-TD-0073-00 | | 510(K) SUMMARY | 2013-03-19 | ## 510(K) SUMMARY This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SDMA 1990 and 21 CFR §807.92. The assigned 510(k) number is: ## 1. Submitter's Identification: GETEMED Medizin- und Informationstechnik AG Oderstrasse 77, 14513 Teltow, Germany Tel: + 49 3328 3942 0 Contact: Dr. Bert Schadow Regulatory Affairs Manager GETEMED Medizin- und Informationstechnik AG Oderstrasse 77, 14513 Teltow, GERMANY Tel: + 49 3328 3942 70 Fax: +49 3328 3942 99 Date Summary prepared: 2013-03-19 - 2. Name of the Device: SEER 1000 - 3. Device Class: Class II - 4. Common or Usual Name: Holter ECG recorder without Analysis #### 5. Predicate Device Information: | Device | Manufacturer | 510(k) Number | |----------------------------------------------------|------------------------------------------------|---------------| | SEER Light Extend Compact<br>Digital Holter System | GE Medical Systems<br>Information Technologies | K050731 | | CardioMem® CM 3000-12BT | GETEMED Medizin- und<br>Informationstechnik AG | K063042 | {1}------------------------------------------------ | DHF - Technical Documentation<br>Image: getemed logo | | |------------------------------------------------------|-----------------| | SEER 1000 | 1015-TD-0073-00 | | 510(K) SUMMARY | 2013-03-19 | ## 6. Device Description: The SEER 1000 Holter recorder is designed to acquire ambulatory 2 or 3 channels of ECG signal from the chest surface of patients for up to 7 days. The device stores the acquired ECG data in its on-board flash memory. Patient demographic information can be downloaded from a PC application or from a mobile application (IPhone, IPod, IPad) into the SEER 1000 recorder via Bluetooth during hookup time. With the PC application or mobile application you can start or stop a recording and you can check signal quality of the ECG data during hookup time or recording. At the end of the recording, the SEER 1000 can be directly connected to a PC via an USB cable to download the recorded data for later evaluation. It is not possible to connect an USB cable and an ECG patient cable to the recorder at the same time. ## 7. Intended Use: The SEER 1000 digital Holter recorder is intended to continuously record ECG data. The SEER 1000 performs no cardiac analysis by itself and is intended to be used with an ECG analysis software package. The recorded data are downloaded to a PC for analysis and subsequent evaluation by a trained physician or health care professional. ## 8. Comparison to Predicate Devices: The SEER 1000 Holter recorder is substantially equivalent to the Holter recorder CardioMem® CM 3000-12BT (K063042) from GETEMED Medizinund Informationstechnik AG and the SEER Light Extend Compact Digital Holter System (K050731) from GE Medical Systems Information Technologies. All Holter recorders record ECG data and don't perform cardiac analysis by themselves. Only some incremental changes in the SEER 1000 were made to improve the usability, the design and to bring the technical details up-to date. Wireless technology is used in the SEER Light (infrared) and CM 3000-12BT and the SEER 1000 (Bluetooth) to transfer patient data and to check the signal quality of ECG data during hookup time and recording. The SEER Light and the SEER 1000 have to be connected to a PC to read out the recorded ECG data for later evaluation. The SEER 1000 design (device without display) and operating principle (handling) is identical to the SEER Light. The SEER Light Extend Controller and the SEER 1000 PC and mobile application are both used to transfer patient data and to check the signal quality of ECG data. No influence on safety and effectiveness has been found. {2}------------------------------------------------ ## DHF - Technical Documentation 510(K) SUMMARY SEER 1000 Ogetemed 1015-TD-0073-00 2013-03-19 ## 9. Discussion of Non-Clinical Tests Performed for Determination of Substantial Equivalence are as follows: Non-clinical testing that has been conducted includes: - a. Electromagnetic compatibility evaluation according to IEC 60601-1-2; - b. Electrical safety test according test to IEC 60601-1 - c. ECG performance test according to AAMI ANSI EC 38 None of the testing demonstrated that the SEER 1000 brought up any issues of safety or effectiveness. ## 10. Discussion of Clinical Tests Performed: No clinical testing was performed in order to support safety or effectiveness. ## 11. Conclusion: The Holter recorder SEER 1000 is identical in indications for use to its predicate device and very similar in functionality, design, material and performance to applicable standards. The main modification is the implementation of the Bluetooth wireless technology as used in the CM 3000-12BT instead infrared as used in the SEER Light. Generally, there was a process of miniaturization for the complete device, so that it is now smaller and lighter. The test results in this submission demonstrated that these small differences do not raise any new questions of safety and effectiveness to the subject device and the subject device is substantially equivalent to the predicate devices. {3}------------------------------------------------ Image /page/3/Picture/0 description: The image shows the logo for the Department of Health & Human Services - USA. The logo features a stylized eagle with three lines representing its body and wings. The eagle is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement. Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 July 26, 2013 GETEMED Medizin-und Informationstechnik AG c/o Dr. Bert Schadow Regulatory Affairs Manager Oderstr. 77 Teltow 14513 GERMANY Re: K130785 > Trade/Device Names: SEER 1000 Regulatory Number: 21 CFR 870.2800 Regulation Name: Medical Magnetic Tape Recorder Regulatory Class: Class II (Two) Product Code: MWJ Dated: June 25, 2013 Received: June 28, 2013 > > r Dear Dr. Schadow: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {4}------------------------------------------------ Page 2 - Dr. Bert Schadow Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDeyices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely vours. M. A. Stillerman for Bram D. Zuckerman Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ # Indications for Use 510(k) Number (if known): Device Name: SEER 1000 Indication for Use: The SEER 1000 is a Holter recorder which is indicated for patients who may benefit from a long-term continuous electrocardiographic (ECG) recording, including, but not limited to, those with complaints of palpitations, syncope, chest pain, shortness of breath, or those that need to be monitored to judge their current cardiac functionality. Prescription Use X __ AND/OR Over-The Counter Use _ (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation . A. S. Hillman Page 1 of ____________________________________________________________________________________________________________________________________________________________________
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...